Related Experiment Video
Updated: Jul 10, 2026
09:37
Substantiating Appropriate Motion Capture Techniques for the Assessment of Nordic Walking Gait and Posture in Older Adults
Published on: May 12, 2016
Nordic track: NIH dysfunction and my Helsinki recruitment
1Department of Diabetes and Cancer Metabolism, Beckman Research Institute, Duarte, CA, USA; Sustainable Wellbeing Across Lifespan, Faculties of Medicine and Pharmacy and the Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Trends in Endocrinology and Metabolism: TEM
|July 8, 2026
Summary
National Institutes of Health funding is shifting away from novel research. Reviewers increasingly penalize innovation and translation, potentially harming U.S. biomedical progress.
Area of Science:
- Biomedical research funding and policy
- Scientific innovation and translation
Background:
- The National Institutes of Health (NIH) traditionally supports groundbreaking and translational research.
- Recent trends show NIH reviewers penalizing novelty and critique of established views.
- Program officers are increasingly refusing to review proposals on certain topics.
Purpose of the Study:
- To analyze the impact of current NIH review practices on scientific progress.
- To highlight the potential negative consequences of discouraging novel and translational research.
Main Methods:
- Analysis of NIH funding and review trends.
- Qualitative assessment of reviewer feedback and program officer guidance.
Main Results:
- Reviewers are increasingly penalizing research for novelty and critique of dogma.
- NIH program officers are instructed to reject proposals on specific 'forbidden' topics.
- These practices may hinder the translation of research findings into clinical applications.
Conclusions:
- Current NIH policies may stifle innovation and impede U.S. biomedical progress.
- The observed trends have contributed to a shift in research laboratory locations.
- A re-evaluation of NIH review criteria is necessary to foster scientific advancement.
